v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities:    
Net loss $ (5,095,518) $ (5,761,801)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,234,749 2,515,177
Amortization of right of use assets - financing 18,209 54,356
Amortization of right of use assets - operating lease 249,804 227,628
Stock based compensation 1,144,773 1,501,444
Amortization of financing fees 0 20,000
Impairment and amortization of referral and support services agreement advance 0 800,000
Adjustment to expected losses on accounts receivable (45,671) (1,442,533)
Deferred income tax expense 10,701 8,028
Derecognition of contingency and grant 0 (35,000)
Change in operating assets and liabilities:    
Accounts receivable 6,703,509 (1,876,282)
Prepaid expenses, other current assets and other assets 150,064 111,320
Accounts payable (1,331,567) 1,990,231
Accrued expenses and other liabilities (5,565,487) 2,329,295
Lease liability - operating lease (259,867) (212,309)
Net cash provided by/(used in) operating activities (1,786,301) 229,554
Investing activities:    
Purchases of equipment and capitalized development costs (1,601,903) (1,857,375)
Net cash provided by/(used in) investing activities (1,601,903) (1,857,375)
Financing activities:    
Proceeds from at-the-market sales, net 1,149,288 0
Proceeds net of payments on Financing Agreement 3,288,100 0
Principal payments on finance lease obligations (18,209) (50,801)
Net taxes paid on restricted stock unit grants exercised (650,299) (302,587)
Net cash provided by/(used in) financing activities 3,768,880 (353,388)
Net change - cash 380,676 (1,981,209)
Cash and cash equivalent, beginning of year 2,459,245 4,440,454
Cash and cash equivalent, end of year 2,839,921 2,459,245
Supplemental information:    
Interest paid 482,420 337,961
Noncash investing and financing activities:    
Acquisition of right of use asset for operating lease liability 0 335,286
Issuance of 3,287,537 restricted stock units to settle accrued incentive liability $ 0 $ 1,055,530